Search results
Lilly's Alzheimer's drug faces delayed reckoning
Axios· 6 hours agoThe outlook for the latest experimental drug shown to delay Alzheimer's disease will come into focus Monday, when ...
FDA panel reviews Eli Lilly Alzheimer's drug ahead of agency decision
Reuters via AOL· 7 hours ago(Reuters) -Outside advisers to the U.S. Food and Drug Administration are meeting on Monday to assess...
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know
Forbes· 13 hours agoA panel of experts advising the Food and Drug Administration could on Monday recommend Eli Lilly’s ...
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 4 hours agoEli Lilly stock edged higher Monday as a panel of advisors to the Food and Drug Administration...
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Reuters via Yahoo News· 4 days agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...
In review of Lilly Alzheimer’s drug, FDA staff focus on safety, patient selection
BioPharma Dive via Yahoo Finance· 4 days agoAn advisory panel is meeting today to discuss whether donanemab is effective across different groups...
Leading Scientific Journal 'Nature' May Retract Groundbreaking Alzheimer’s Study Over Image...
Men's Journal via Yahoo News· 4 days agoRenowned journal Nature may retract a landmark Alzheimer’s study published back in 2006 over...
Eli Lilly hits an all-time high. Wall Street handicaps Monday's key Alzheimer's drug meeting
CNBC· 3 days agoEvery weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20...
Lifestyle Changes Significantly Improve Cognition and Function in Early Alzheimer's Disease for the...
KNDO - KNDU Tri-Cities· 3 days agoFor the first time, a randomized controlled clinical trial has demonstrated that an intensive lifestyle intervention, without drugs, significantly improved cognition and function after 20 weeks ...
Dow Jones Futures Fall; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
Investor's Business Daily· 6 hours agoFDA Panel Reviews Eli Lilly's Alzheimer's Drug An FDA advisory panel on Monday will review Eli...